Bio-Thera Solutions Balance Sheet Health
Financial Health criteria checks 3/6
Bio-Thera Solutions has a total shareholder equity of CN¥847.3M and total debt of CN¥702.0M, which brings its debt-to-equity ratio to 82.8%. Its total assets and total liabilities are CN¥2.3B and CN¥1.5B respectively.
Key information
82.8%
Debt to equity ratio
CN¥701.97m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥451.10m |
| Equity | CN¥847.30m |
| Total liabilities | CN¥1.49b |
| Total assets | CN¥2.34b |
Recent financial health updates
No updates
Recent updates
Optimistic Investors Push Bio-Thera Solutions, Ltd. (SHSE:688177) Shares Up 44% But Growth Is Lacking
Oct 09
Time To Worry? Analysts Just Downgraded Their Bio-Thera Solutions, Ltd. (SHSE:688177) Outlook
Sep 05Bio-Thera Solutions, Ltd. (SHSE:688177) Shares May Have Slumped 30% But Getting In Cheap Is Still Unlikely
Jun 06Some Confidence Is Lacking In Bio-Thera Solutions, Ltd. (SHSE:688177) As Shares Slide 27%
Apr 18Subdued Growth No Barrier To Bio-Thera Solutions, Ltd. (SHSE:688177) With Shares Advancing 30%
Mar 04Financial Position Analysis
Short Term Liabilities: 688177's short term assets (CN¥1.0B) do not cover its short term liabilities (CN¥1.1B).
Long Term Liabilities: 688177's short term assets (CN¥1.0B) exceed its long term liabilities (CN¥410.8M).
Debt to Equity History and Analysis
Debt Level: 688177's net debt to equity ratio (29.6%) is considered satisfactory.
Reducing Debt: 688177's debt to equity ratio has increased from 11.3% to 82.8% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 688177 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if 688177 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.